Daniel Snell

676 total citations
14 papers, 516 citations indexed

About

Daniel Snell is a scholar working on Hematology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Daniel Snell has authored 14 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Molecular Biology and 4 papers in Immunology and Allergy. Recurrent topics in Daniel Snell's work include Platelet Disorders and Treatments (6 papers), Cell Adhesion Molecules Research (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Daniel Snell is often cited by papers focused on Platelet Disorders and Treatments (6 papers), Cell Adhesion Molecules Research (4 papers) and Glycosylation and Glycoproteins Research (2 papers). Daniel Snell collaborates with scholars based in United Kingdom, United States and Germany. Daniel Snell's co-authors include Steve P. Watson, Gavin E. Jarvis, Ben Atkinson, Oscar Berlanga, Denise Best, Jonathan I. Wilde, David Tulasne, Stuart Marshall, Bernhard Nieswandt and Naoki Asazuma and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Biochemical Journal.

In The Last Decade

Daniel Snell

14 papers receiving 508 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Snell United Kingdom 9 291 179 109 93 84 14 516
D. Alice United States 11 277 1.0× 249 1.4× 107 1.0× 24 0.3× 26 0.3× 24 602
Véronique Dubernard France 12 219 0.8× 147 0.8× 25 0.2× 37 0.4× 98 1.2× 20 430
Christelle Perrault France 8 174 0.6× 86 0.5× 27 0.2× 25 0.3× 19 0.2× 10 329
Teresa Larson United Kingdom 7 368 1.3× 629 3.5× 50 0.5× 52 0.6× 27 0.3× 8 943
Guo Ding Japan 9 127 0.4× 446 2.5× 174 1.6× 37 0.4× 27 0.3× 13 717
Marsha Crochiere United States 12 84 0.3× 471 2.6× 38 0.3× 21 0.2× 49 0.6× 35 618
Sabine Gesierich Germany 7 50 0.2× 519 2.9× 102 0.9× 15 0.2× 18 0.2× 7 650
Megan Kaba United States 4 277 1.0× 281 1.6× 75 0.7× 112 1.2× 76 0.9× 4 675
Maria Grazia Cipolleschi Italy 14 135 0.5× 178 1.0× 33 0.3× 5 0.1× 31 0.4× 21 436
Mehdi El Hour Belgium 5 46 0.2× 174 1.0× 26 0.2× 12 0.1× 44 0.5× 5 345

Countries citing papers authored by Daniel Snell

Since Specialization
Citations

This map shows the geographic impact of Daniel Snell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Snell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Snell more than expected).

Fields of papers citing papers by Daniel Snell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Snell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Snell. The network helps show where Daniel Snell may publish in the future.

Co-authorship network of co-authors of Daniel Snell

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Snell. A scholar is included among the top collaborators of Daniel Snell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Snell. Daniel Snell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Luke, Jason J., Melissa L. Johnson, Shirish M. Gadgeel, et al.. (2022). 732 First-in-human trial to evaluate safety, PK/PD and initial clinical activity of NM21–1480, an affinity-balanced PD-L1x4–1BBxHSA trispecific antibody: results of phase 1 dose escalation. Regular and Young Investigator Award Abstracts. A764–A764. 3 indexed citations
2.
Sipos, Bence, Franziska Eckert, Christian Seitz, et al.. (2015). Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo. Annals of Hematology. 94(11). 1907–1919. 6 indexed citations
3.
Haarer, Jan, Silvio Nadalin, Thomas Joos, et al.. (2014). Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR. Bone Marrow Transplantation. 50(3). 390–401. 3 indexed citations
4.
Dong, Aling, Christopher Seidel, Daniel Snell, et al.. (2013). Antagonism of PDGF-BB suppresses subretinal neovascularization and enhances the effects of blocking VEGF-A. Angiogenesis. 58 indexed citations
5.
McKenzie, Edward A., James M. Bennett, Robert Felix, et al.. (2003). Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells. Biochemical Journal. 373(2). 423–435. 102 indexed citations
6.
Auger, Jocelyn M., Denise Best, Daniel Snell, Jonathan I. Wilde, & Steve P. Watson. (2003). c-Cbl negatively regulates platelet activation by glycoprotein VI. Journal of Thrombosis and Haemostasis. 1(11). 2419–2426. 24 indexed citations
7.
Berlanga, Oscar, David Tulasne, Daniel Snell, et al.. (2002). The Fc receptor γ‐chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C‐type lectin, convulxin. European Journal of Biochemistry. 269(12). 2951–2960. 41 indexed citations
8.
Jarvis, Gavin E., Ben Atkinson, Daniel Snell, & Steve P. Watson. (2002). Distinct roles of GPVI and integrin α2β1 in platelet shape change and aggregation induced by different collagens. British Journal of Pharmacology. 137(1). 107–117. 62 indexed citations
9.
Snell, Daniel, Valerie Schulte, Gavin E. Jarvis, et al.. (2002). Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands. Biochemical Journal. 368(1). 293–300. 46 indexed citations
10.
Asazuma, Naoki, Stuart Marshall, Oscar Berlanga, et al.. (2001). The snake venom toxin alboaggregin-A activates glycoprotein VI. Blood. 97(12). 3989–3991. 24 indexed citations
11.
Schulte, Valerie, Daniel Snell, Wolfgang Bergmeier, et al.. (2001). Evidence for Two Distinct Epitopes within Collagen for Activation of Murine Platelets. Journal of Biological Chemistry. 276(1). 364–368. 34 indexed citations
12.
Asazuma, Naoki, Ben Atkinson, Oscar Berlanga, et al.. (2001). The Role of ITAM- and ITIM-coupled Receptors in Platelet Activation by Collagen. Thrombosis and Haemostasis. 86(7). 276–288. 110 indexed citations
13.
Fleming, Daniel Ε. & Daniel Snell. (1998). Life in the Ancient Near East: 3100-322 B.C.E.. Journal of Biblical Literature. 117(4). 718–718. 1 indexed citations
14.
Snell, Daniel. (1982). Plagues and Peoples in Mesopotamia. 14(1). 2302. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026